The Vascular Endothelial Growth Factor (VEGF)/VEGF receptor (VEGFR) axis is the most prominent pathway both in physiological and tumour-induced neo-angiogenesis and is a therapeutic target in different types of cancers [21]. The gene discussed is VEGFA; the disease is cancer.